This included heart attack and stroke, by 20% in adults with obesity or overweight who already had cardiovascular disease, even without diabetes (Reference)
Nayan Patel Supplement Guide In my telehealth clinic, Im often asked about supplementswhat to take, why, and which brands are best
For example, in the SELECT trial (17,600 patients with cardiovascular disease and obesity but without T2D), weekly subcutaneous Semaglutide (2.4 mg) reduced the risk of major adverse cardiovascular events (MACE heart attack, stroke, or cardiovascular death) by 20% compared to placebo (HR 0.80
Despite this progress, only 14% of patients remain on Wegovy after three years (Figure 3)
Daily Dose: Shake well
Home About Us Give Our Donors Board Mission In Action Events Halloween Hustle Contact More NTMC Foundation